US Stock MarketDetailed Quotes

Mangoceuticals (MGRX)

Watchlist
  • 0.4400
  • +0.0469+11.93%
Close May 15 15:59 ET
7.47MMarket Cap-0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mangoceuticals (MGRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-20.28%-5.85M
4.59%-1.08M
-6.47%-1.24M
20.34%-1.26M
-129.51%-2.27M
30.49%-4.86M
33.47%-1.13M
31.85%-1.17M
11.42%-1.58M
45.19%-991.13K
Net income from continuing operations
-137.08%-20.64M
-42.12%-2.77M
-281.00%-7.62M
-126.48%-5.42M
-104.40%-4.84M
5.48%-8.71M
24.12%-1.95M
-11.13%-2M
-4.70%-2.39M
7.55%-2.37M
Operating gains losses
688.67%145.01K
--19.39K
----
----
----
--18.39K
--0
--0
----
----
Depreciation and amortization
135.72%1.72M
-37.91%448.15K
185.62%24.83K
2,476.52%836.23K
6,567.61%414.99K
815.85%731.47K
1,078.04%721.79K
-560.89%-29K
421.47%32.46K
2.33%6.22K
Other non cash items
397.93%10.79M
-81.67%80.26K
1,004.82%5.56M
304.01%3.19M
349.23%1.95M
42.11%2.17M
37.67%437.93K
411.00%503.21K
94.62%789.88K
-38.01%435.02K
Change In working capital
-140.81%-269.47K
-215.76%-62.66K
-4,762.36%-432.29K
126.96%80.96K
-83.89%144.52K
5,003.67%660.38K
-12.51%54.13K
111.18%9.27K
-1,208.24%-300.3K
4,694.36%897.28K
-Change in receivables
---20.06K
----
----
----
----
--0
----
----
----
----
-Change in inventory
----
----
--0
--0
--0
--0
-271.69%-5.29K
-57.87%806
119.08%4.48K
--0
-Change in prepaid assets
-139.54%-24.1K
--75.9K
-851.94%-100K
77.99%83.21K
-9,325.50%-83.21K
223.87%60.95K
--0
142.06%13.3K
317.60%46.75K
104.62%902
-Change in payables and accrued expense
-89.72%65.09K
-547.32%-93.21K
-942.89%-305.17K
136.56%122.79K
-62.64%340.68K
470.45%633.02K
-58.41%20.84K
192.66%36.21K
-436.02%-335.81K
--911.79K
-Change in other current assets
----
----
----
----
8.63%15.72K
----
----
----
-45.42%14.78K
--14.47K
-Change in other current liabilities
-764.43%-290.4K
-165.56%-25.29K
33.90%-27.13K
-695.32%-125.04K
-632.84%-112.95K
40.78%-33.6K
361.61%38.58K
-190.68%-41.04K
43.57%-15.72K
---15.41K
Cash from discontinued investing activities
Operating cash flow
-20.28%-5.85M
4.59%-1.08M
-6.47%-1.24M
20.34%-1.26M
-129.51%-2.27M
30.49%-4.86M
33.47%-1.13M
31.85%-1.17M
11.42%-1.58M
45.19%-991.13K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
1,947.12%65K
0
0
65K
0
Net PPE purchase and sale
----
----
----
----
----
--0
--0
---65K
--65K
--0
Net other investing changes
----
----
----
----
----
--65K
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
----
----
1,947.12%65K
--0
--0
--65K
--0
Financing cash flow
Cash flow from continuing financing activities
76.12%7.27M
85.61%2.08M
116.21%1.62M
-35.58%1.28M
754.21%2.29M
-41.50%4.13M
-6.46%1.12M
750K
131.99%1.99M
-94.65%267.5K
Net issuance payments of debt
212.33%468.5K
-250.67%-131.5K
--0
500.00%600K
--0
189.57%150K
---37.5K
--0
159.72%100K
--87.5K
Net common stock issuance
248.22%4.63M
191.45%2.21M
--1.32M
10.95%430.79K
263.89%655K
-78.58%1.33M
-36.67%760K
--0
--388.27K
-96.40%180K
Net preferred stock issuance
-96.23%100K
--0
--0
-170.00%-1.05M
--1.15M
--2.65M
--400K
--750K
--1.5M
--0
Proceeds from stock option exercised by employees
--927K
--0
---853K
--1.3M
--480K
--0
--0
--0
--0
--0
Net other financing activities
--1.15M
--0
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
76.12%7.27M
85.61%2.08M
116.21%1.62M
-35.58%1.28M
754.21%2.29M
-41.50%4.13M
-6.46%1.12M
--750K
131.99%1.99M
-94.65%267.5K
Net cash flow
Beginning cash position
-92.06%58.65K
551.15%481.28K
-79.39%101.02K
399.81%76.5K
-92.06%58.65K
8.22%739.01K
-94.02%73.91K
-83.37%490.24K
-99.60%15.31K
8.22%739.01K
Current changes in cash
311.87%1.42M
14,311.36%1.01M
191.46%380.31K
-94.89%24.34K
101.41%10.22K
-1,294.22%-670.51K
98.58%-7.08K
75.69%-415.83K
151.54%476.03K
-122.70%-723.63K
Effect of exchange rate changes
171.97%7.09K
91.68%-681
90.95%-45
117.06%187
10,991.43%7.62K
---9.85K
---8.18K
---497
---1.1K
---70
End cash Position
2,434.12%1.49M
2,434.12%1.49M
551.15%481.28K
-79.39%101.02K
399.81%76.5K
-92.06%58.65K
-92.06%58.65K
-94.02%73.91K
-83.37%490.24K
-99.60%15.31K
Free cash flow
-20.28%-5.85M
4.59%-1.08M
-6.47%-1.24M
20.34%-1.26M
-129.51%-2.27M
30.53%-4.86M
33.47%-1.13M
31.85%-1.17M
11.42%-1.58M
45.30%-991.13K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -20.28%-5.85M4.59%-1.08M-6.47%-1.24M20.34%-1.26M-129.51%-2.27M30.49%-4.86M33.47%-1.13M31.85%-1.17M11.42%-1.58M45.19%-991.13K
Net income from continuing operations -137.08%-20.64M-42.12%-2.77M-281.00%-7.62M-126.48%-5.42M-104.40%-4.84M5.48%-8.71M24.12%-1.95M-11.13%-2M-4.70%-2.39M7.55%-2.37M
Operating gains losses 688.67%145.01K--19.39K--------------18.39K--0--0--------
Depreciation and amortization 135.72%1.72M-37.91%448.15K185.62%24.83K2,476.52%836.23K6,567.61%414.99K815.85%731.47K1,078.04%721.79K-560.89%-29K421.47%32.46K2.33%6.22K
Other non cash items 397.93%10.79M-81.67%80.26K1,004.82%5.56M304.01%3.19M349.23%1.95M42.11%2.17M37.67%437.93K411.00%503.21K94.62%789.88K-38.01%435.02K
Change In working capital -140.81%-269.47K-215.76%-62.66K-4,762.36%-432.29K126.96%80.96K-83.89%144.52K5,003.67%660.38K-12.51%54.13K111.18%9.27K-1,208.24%-300.3K4,694.36%897.28K
-Change in receivables ---20.06K------------------0----------------
-Change in inventory ----------0--0--0--0-271.69%-5.29K-57.87%806119.08%4.48K--0
-Change in prepaid assets -139.54%-24.1K--75.9K-851.94%-100K77.99%83.21K-9,325.50%-83.21K223.87%60.95K--0142.06%13.3K317.60%46.75K104.62%902
-Change in payables and accrued expense -89.72%65.09K-547.32%-93.21K-942.89%-305.17K136.56%122.79K-62.64%340.68K470.45%633.02K-58.41%20.84K192.66%36.21K-436.02%-335.81K--911.79K
-Change in other current assets ----------------8.63%15.72K-------------45.42%14.78K--14.47K
-Change in other current liabilities -764.43%-290.4K-165.56%-25.29K33.90%-27.13K-695.32%-125.04K-632.84%-112.95K40.78%-33.6K361.61%38.58K-190.68%-41.04K43.57%-15.72K---15.41K
Cash from discontinued investing activities
Operating cash flow -20.28%-5.85M4.59%-1.08M-6.47%-1.24M20.34%-1.26M-129.51%-2.27M30.49%-4.86M33.47%-1.13M31.85%-1.17M11.42%-1.58M45.19%-991.13K
Investing cash flow
Cash flow from continuing investing activities 0001,947.12%65K0065K0
Net PPE purchase and sale ----------------------0--0---65K--65K--0
Net other investing changes ----------------------65K--0--0--------
Cash from discontinued investing activities
Investing cash flow --0--0--0--------1,947.12%65K--0--0--65K--0
Financing cash flow
Cash flow from continuing financing activities 76.12%7.27M85.61%2.08M116.21%1.62M-35.58%1.28M754.21%2.29M-41.50%4.13M-6.46%1.12M750K131.99%1.99M-94.65%267.5K
Net issuance payments of debt 212.33%468.5K-250.67%-131.5K--0500.00%600K--0189.57%150K---37.5K--0159.72%100K--87.5K
Net common stock issuance 248.22%4.63M191.45%2.21M--1.32M10.95%430.79K263.89%655K-78.58%1.33M-36.67%760K--0--388.27K-96.40%180K
Net preferred stock issuance -96.23%100K--0--0-170.00%-1.05M--1.15M--2.65M--400K--750K--1.5M--0
Proceeds from stock option exercised by employees --927K--0---853K--1.3M--480K--0--0--0--0--0
Net other financing activities --1.15M--0--------------------------------
Cash from discontinued financing activities
Financing cash flow 76.12%7.27M85.61%2.08M116.21%1.62M-35.58%1.28M754.21%2.29M-41.50%4.13M-6.46%1.12M--750K131.99%1.99M-94.65%267.5K
Net cash flow
Beginning cash position -92.06%58.65K551.15%481.28K-79.39%101.02K399.81%76.5K-92.06%58.65K8.22%739.01K-94.02%73.91K-83.37%490.24K-99.60%15.31K8.22%739.01K
Current changes in cash 311.87%1.42M14,311.36%1.01M191.46%380.31K-94.89%24.34K101.41%10.22K-1,294.22%-670.51K98.58%-7.08K75.69%-415.83K151.54%476.03K-122.70%-723.63K
Effect of exchange rate changes 171.97%7.09K91.68%-68190.95%-45117.06%18710,991.43%7.62K---9.85K---8.18K---497---1.1K---70
End cash Position 2,434.12%1.49M2,434.12%1.49M551.15%481.28K-79.39%101.02K399.81%76.5K-92.06%58.65K-92.06%58.65K-94.02%73.91K-83.37%490.24K-99.60%15.31K
Free cash flow -20.28%-5.85M4.59%-1.08M-6.47%-1.24M20.34%-1.26M-129.51%-2.27M30.53%-4.86M33.47%-1.13M31.85%-1.17M11.42%-1.58M45.30%-991.13K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +33.98%
Sample Name
Sample Code
 +27.69%
Sample Name
Sample Code
 +26.85%
4
United States Gasoline Fund Lp
UGA
+26.35%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.41%
Sample Name
Sample Code
 +10.81%
Sample Name
Sample Code
 +6.19%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -